1887

Journal of General Virology header logo

Volume 85, Issue 12

Functional comparison of the two gene products of segment 6 Free

Abstract

The sixth genomic segment of (THOV) encodes two proteins, the viral matrix protein (M) and an accessory protein with an interferon (IFN)-antagonistic function named ML. M and ML are shown in this study to be structural components of the virion. Using an system based on the reconstitution of functional THOV ribonucleoprotein complexes from cloned cDNAs, it was demonstrated that M has an inhibitory effect on the viral RNA-dependent RNA polymerase (RdRP) and is essential for the formation of virus-like particles (VLPs). The functional domain responsible for the regulation of RdRP activity resides within the C-terminal half of M, while full-length M protein is required for VLP formation. The ML protein cannot complement M with respect to either RdRP downregulation or particle formation, although it is identical to M apart from a 38 aa extension at the C terminus. In contrast, ML, but not M, is able to prevent the induction of IFN- by double-stranded RNA. This function is contained within the C-terminal half of ML. These data suggest major structural differences between M and ML that could explain the different activities of the two proteins.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80300-0
2004-12-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/12/vir853699.html?itemId=/content/journal/jgv/10.1099/vir.0.80300-0&mimeType=html&fmt=ahah

References

  1. Anderson C. R., Casals J. 1973; Dhori virus, a new agent isolated from Hyalomma dromedarii in India. Indian J Med Res 61:1416–1420
     [Google Scholar]
  2. Basler C. F., Wang X., Mühlberger E., Volchkov V., Paragas J., Klenk H.-D., Garcia-Sastre A., Palese P. 2000; The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 97:12289–12294 [CrossRef]
     [Google Scholar]
  3. Baudin F., Petit I., Weissenhorn W., Ruigrock R. W. H. 2001; In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 281:102–108 [CrossRef]
     [Google Scholar]
  4. Bazzigher L., Pavlovic J., Haller O., Staeheli P. 1992; Mx genes show weaker primary response to virus than other interferon-regulated genes. Virology 186:154–160 [CrossRef]
     [Google Scholar]
  5. Bourmakina S. V., Garcia-Sastre A. 2003; Reverse genetics studies on the filamentous morphology of influenza A virus. J Gen Virol 84:517–527 [CrossRef]
     [Google Scholar]
  6. Browne E. P., Shenk T. 2003; Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A 100:11439–11444 [CrossRef]
     [Google Scholar]
  7. Bui M., Wills E. G., Helenius A., Whittaker G. R. 2000; Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol 74:1781–1786 [CrossRef]
     [Google Scholar]
  8. Clouthier S. C., Rector T., Brown N. E., Anderson E. D. 2002; Genomic organization of infectious salmon anaemia virus. J Gen Virol 83:421–428
     [Google Scholar]
  9. Compans R. W., Dimmock N. J. 1969; An electron microscopic study of single-cycle infection of chick embryo fibroblasts by influenza virus. Virology 39:499–515 [CrossRef]
     [Google Scholar]
  10. Elleman C. J., Barclay W. S. 2004; The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321:144–153 [CrossRef]
     [Google Scholar]
  11. Filipe A. R., Calisher C. H. 1984; Isolation of Thogoto virus from ticks in Portugal. Acta Virol 28:152–155
     [Google Scholar]
  12. Finke S., Mueller-Waldeck R., Conzelmann K. 2003; Rabies virus matrix protein regulates the balance of virus transcription and replication. J Gen Virol 84:1613–1621 [CrossRef]
     [Google Scholar]
  13. Garcia-Sastre A., Egorov A., Matassov D., Brandt S., Levy D. E., Durbin J. E., Palese P., Muster T. 1998; Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330 [CrossRef]
     [Google Scholar]
  14. Gaudier M., Gaudin Y., Knossow M. 2002; Crystal structure of vesicular stomatitis virus matrix protein. EMBO J 21:2886–2892 [CrossRef]
     [Google Scholar]
  15. Gelderblom H. R., Hausmann E. H. S., Özel M., Pauli G., Koch M. A. 1987; Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171–176 [CrossRef]
     [Google Scholar]
  16. Georgiev O., Bourquin J. P., Gstaiger M., Knoepfel L., Schaffner W., Hovens C. 1996; Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteins. Gene 168:165–167 [CrossRef]
     [Google Scholar]
  17. Gomez-Puertas P., Albo C., Perez-Pastrana E., Vivo A., Portela A. 2000; Influenza virus matrix protein is the major driving force in virus budding. J Virol 74:11538–11547 [CrossRef]
     [Google Scholar]
  18. Gorman M., Moffat L. F., Howard B. H. 1982; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044–1051
     [Google Scholar]
  19. Hagmaier K., Jennings S., Buse J., Weber F., Kochs G. 2003; Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist. J Virol 77:2747–2752 [CrossRef]
     [Google Scholar]
  20. Haller O., Kochs G. 2002; Thogotovirus. In The Springer Index of Viruses pp  615–619 Edited by Tidona C. A., Darai G. Berlin/Heidelberg/New York: Springer;
     [Google Scholar]
  21. Haller O., Frese M., Rost D., Nuttall P., Kochs G. 1995; Tick-borne Thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J Virol 69:2596–2601
     [Google Scholar]
  22. Hopp T. P. 1988; A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology 6:1204–1210 [CrossRef]
     [Google Scholar]
  23. Israel A. 1979; Preliminary characterization of the particles from productive and abortive infections of L cells by fowl plague virus. Ann Microbiol 130B:85–100
     [Google Scholar]
  24. Jones J. D., Nuttall P. A. 1989; The effect of virus-immune hosts on Thogoto virus infection of the tick, Rhipicephalus appendiculatus . Virus Res 14:129–140 [CrossRef]
     [Google Scholar]
  25. Kaptur P. E., Rhodes R. B., Lyles D. S. 1991; Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids. J Virol 65:1057–1065
     [Google Scholar]
  26. Kochs G., Weber F., Gruber S., Delvendahl A., Leitz C., Haller O. 2000; Thogoto virus matrix protein is encoded by a spliced mRNA. J Virol 74:10785–10789 [CrossRef]
     [Google Scholar]
  27. Lamb R. A., Krug R. M. 2001; Orthomyxoviridae : the viruses and their replication. In Fields Virology , 4th edn. pp  1487–1532 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott Williams and Wilkins;
     [Google Scholar]
  28. Lenard J. 1996; Negative-strand virus M and retrovirus MA proteins: all in a family. Virology 216:289–298 [CrossRef]
     [Google Scholar]
  29. Martin K., Helenius A. 1991; Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117–130 [CrossRef]
     [Google Scholar]
  30. Perez D. R., Donis R. O. 1998; The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. Virology 249:52–61 [CrossRef]
     [Google Scholar]
  31. Roberts P. C., Lamb R. A., Compans R. W. 1998; The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240:127–137 [CrossRef]
     [Google Scholar]
  32. Ruigrok R. W. H., Barge A., Durrer P., Brunner J., Ma K., Whittaker G. R. 2000; Membrane interaction of influenza virus M1 protein. Virology 267:289–298 [CrossRef]
     [Google Scholar]
  33. Scianimanico S., Schoehn G., Timmins J., Ruigrock R. W. H., Klenk H.-D., Weissenhorn W. 2000; Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J 19:6732–6741 [CrossRef]
     [Google Scholar]
  34. Sha B., Luo M. 1997; Structure of a bifunctional membrane–RNA binding protein, influenza virus matrix protein M1. Nat Struct Biol 4:239–244 [CrossRef]
     [Google Scholar]
  35. Siebler J., Haller O., Kochs G. 1996; Thogoto and Dhori virus replication is blocked by inhibitors of cellular polymerase II activity but does not cause shutoff of host cell protein synthesis. Arch Virol 141:1587–1594 [CrossRef]
     [Google Scholar]
  36. Smirnov Y. A., Kuznetsova M. A., Kaverin N. V. 1991; The genetic aspects of influenza virus filamentous particle formation. Arch Virol 118:279–284 [CrossRef]
     [Google Scholar]
  37. Sutter G., Ohlmann M., Erfle V. 1995; Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 371:9–12 [CrossRef]
     [Google Scholar]
  38. Timmins J., Scianimanico S., Schoen G., Weissenhorn W. 2001; Vesicular release of Ebola virus matrix protein VP40. Virology 283:1–6 [CrossRef]
     [Google Scholar]
  39. van Regenmortel M. H. V., Fauquet C. M., Bishop D. H. L. , 8 other editors. 2000; Virus Taxonomy: the Classification and Nomenclature of Viruses . Seventh Report of the International Committee on Taxonomy of Viruses San Diego: Academic Press;
     [Google Scholar]
  40. Wagner E., Engelhardt O. G., Weber F., Haller O., Kochs G. 2000; Formation of virus-like particles from cloned cDNA of Thogoto virus. J Gen Virol 81:2849–2853
     [Google Scholar]
  41. Watanabe K., Handa H., Mizumoto K., Nagata K. 1996; Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J Virol 70:241–247
     [Google Scholar]
  42. Weber F., Haller O., Kochs G. 2000; MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J Virol 74:560–563 [CrossRef]
     [Google Scholar]
  43. Weber F., Bridgen A., Fazakerley J. K., Streitenfeld H., Kessler N., Randall R. E., Elliott R. M. 2002; Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76:7949–7955 [CrossRef]
     [Google Scholar]
  44. Whittaker G., Bui M., Helenius A. 1996; Nuclear trafficking of influenza virus ribonucleoproteins in heterokaryons. J Virol 70:2743–2756
     [Google Scholar]
  45. Ye Z., Liu T., Offringa D. P., McInnis J., Levandowski R. A. 1999; Association of influenza virus matrix protein with ribonucleoproteins. J Virol 73:7467–7473
     [Google Scholar]
  46. Ye Z., Pal R., Fox J. W., Wagner R. R. 1987; Functional and antigenic domains of the matrix (M1) protein of influenza virus. J Virol 61:239–246
     [Google Scholar]
  47. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., Fujita T. 1998; Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17:1087–1095 [CrossRef]
     [Google Scholar]
  48. Zhang J., Lamb R. A. 1996; Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology 225:255–266 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80300-0
Loading
Functional comparison of the two gene products of Thogoto virus segment 6
J. Gen. Virol. 85, 3699 (2004); https://doi.org/10.1099/vir.0.80300-0
/content/journal/jgv/10.1099/vir.0.80300-0
/content/journal/jgv/10.1099/vir.0.80300-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error